论文部分内容阅读
目的观察胸腺五肽辅助治疗慢性阻塞性肺病(COPD)的疗效。方法将78例COPD患者随机分为2组,对照组给予常规治疗,治疗组加用胸腺五肽,观察比较2组患者症状体征缓解时间、平均住院时间以及3个月内再入院率。结果治疗组症状体征缓解时间、平均住院时间均较对照组显著缩短(P<0.05),治疗组3个月内再入院率较对照组显著降低(P<0.05)。结论胸腺五肽可增强COPD患者的免疫功能,缩短平均住院时间,降低再发风险,提高患者生活质量。
Objective To observe the therapeutic effect of thymopentin in the treatment of chronic obstructive pulmonary disease (COPD). Methods 78 patients with COPD were randomly divided into two groups. The control group was treated with conventional therapy. Thymopentin was used in the treatment group. The symptom and symptom relief time, average length of hospital stay and rehospitalization rate within 3 months were compared between the two groups. Results The symptom and symptom relief time and average length of stay in treatment group were significantly shorter than those in control group (P <0.05). The readmission rate within 3 months in treatment group was significantly lower than that in control group (P <0.05). Conclusion Thymopentin can enhance the immune function of patients with COPD, shorten the average length of stay, reduce the risk of recurrence and improve the quality of life of patients.